Brief

Cowen & Co. Believes Array Biopharma (ARRY) Won’t Stop Here

In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on Array Biopharma (ARRY), with a price target …

Cowen & Co. Believes Voyager Therapeutics Inc (VYGR) Won’t Stop Here

Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Voyager Therapeutics Inc (VYGR) today.

H.C. Wainwright Sticks to Its Buy Rating for Pieris Pharmaceuticals (PIRS)

In a report released today, Joseph Pantginis from H.C.

The CEO & President of Sharps Compliance Corp (SMED) is Buying Shares

Today, the CEO & President of Sharps Compliance Corp (SMED), David Tusa, bought shares of SMED for $16.5K.

The VP & CFO of Sharps Compliance Corp (SMED) is Buying Shares

Today, the VP & CFO of Sharps Compliance Corp (SMED), Diana Diaz, bought shares of SMED for $4,175. This recent transaction increases Diana …

Prosperity Bancshares (PB) Gets a Hold Rating from Stephens

Stephens analyst Matt Olney maintained a Hold rating on Prosperity Bancshares (PB) today and set a price target of $74. The company’s shares …

Susquehanna Maintains a Buy Rating on Corning Inc (GLW)

Susquehanna analyst Mehdi Hosseini maintained a Buy rating on Corning Inc (GLW) today and set a price target of $40. The company’s shares …

Monness Believes MongoDB Inc (MDB) Still Has Room to Grow

In a report released today, Brian White from Monness maintained a Buy rating on MongoDB Inc (MDB), with a price target of $185. …

Chardan Capital Thinks Seres Therapeutics’ Stock is Going to Recover

In a report released today, Taylor Feehley from Chardan Capital reiterated a Buy rating on Seres Therapeutics (MCRB). The company’s shares closed on …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts